Premium
Healthcare-focused private equity firm Somerset Indus Capital Partners is considering exiting a nutritional supplements maker...
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
